Pharmacy Magazine UK Touts the Ivermectin’s Positive Potential Targeting COVID-19

Pharmacy Magazine UK Touts the Ivermectin’s Positive Potential Targeting COVID-19

Pharmacy Magazine in the United Kingdom recently reports on the positive attributes of ivermectin. For example, the drug is included in the WHO Model List of Essential Medicines and more interestingly, and perhaps controversially for some, the UK online media reports on the recent British Ivermectin Recommendation Development (BIRD) Group recommendation that the drug be immediately rolled out to the public for the prevention of COVID-19, at least on an emergency basis.

Why does this online media make this recommendation?

First and foremost, the drug at established human doses is safe, widely used to treat a number of human parasites since the 1980s. Since then, some 4 billion doses have been consumed by humans with what Pharmacy Magazine UK declares is a “good safety record with minimal toxic effects.”

What evidence backs their position?

Pharmacy Magazine shared the recent meta-analysis of 15 randomized controlled trials coupled with observational studies demonstrating significant safety and efficacy both for treatment and prophylaxis targeting COVID-19.

How many patients did this 15 trial meta-analysis cover?

Nearly 4,000 patients.

Do some studies show that i...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee